SirTlab Corporation

Genetic Treatment for Age-related Diseases

Health Tech & Life Sciences
Active
Seed Ramat Gan, Israel Founded 2012
Website ↗
Last updated 2026-06-18
Total raised
$1.5M
Last: 2025-05
Stage
Seed
Founded
2012
Headcount
6
HQ
Ramat Gan, Israel
Sector
Health Tech & Life Sciences

About

SirTLab is the leader in Restoring SIRT6 Expression for Severe Liver Diseases and Diseases of Aging.

Sirtuin 6 (SIRT6) is a Key Regulator for Health in all cells. Levels of SIRT6 are reduced in liver diseases: NASH1, other cirrhosis, metabolic syndrome, acetaminophen toxicity.

SIRTLab patented SIRT6-mRNA-LNP2 for liver specific expression of SIRT6 is based on 18 years of research.

Funding history · 3 rounds · $1.5M total

2025-05
$486K
2021-12
Grant $889K
2021-12
$156K

Q&A

What is SirTlab Corporation's primary focus?
SirTlab Corporation specializes in genetic treatment for age-related diseases, particularly focusing on restoring SIRT6 expression for severe liver diseases and other diseases of aging.
When was SirTlab Corporation founded?
SirTlab Corporation was founded in January 2012.
How many employees does SirTlab Corporation currently have?
SirTlab Corporation has 1-10 employees.
What is SirTlab Corporation's total funding to date?
SirTlab Corporation has raised a total of $1,530,208.
When was SirTlab Corporation's most recent funding round and who participated?
SirTlab Corporation's most recent funding round occurred in May 2025, with participation from PipelBiz.
Has SirTlab Corporation received any grants?
Yes, SirTlab Corporation received an $888,888 grant in December 2021 from the BIRD Foundation.
Does SirTlab Corporation hold any patents?
Yes, SirTlab Corporation holds one patent related to its SIRT6-mRNA-LNP2 technology for liver-specific expression of SIRT6.
Who is the CEO and Chairman of SirTlab Corporation?
Boaz Misholi is the CEO and Chairman of SirTlab Corporation.

Team · 1

Founder · CEO & Chairman
LinkedIn ↗

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & Development
Technologies
BiologicalsGenes
Target customers
Healthcare & Life SciencesLife SciencesPharmaceuticals
Business model
B2BB2C

Highlights

1 Patents

Tags

anti-agingtherapeuticspharmaceuticalsgeneticspharma-companieschronic-patients
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)